title: Non-esterified fatty acids generate distinct low-molecular weight amyloid-β (Aβ42) oligomers along pathway different from fibril formation.
abstract: Amyloid-β (Aβ) peptide aggregation is known to play a central role in the etiology of Alzheimer's disease (AD). Among various aggregates, low-molecular weight soluble oligomers of Aβ are increasingly believed to be the primary neurotoxic agents responsible for memory impairment. Anionic interfaces are known to influence the Aβ aggregation process significantly. Here, we report the effects of interfaces formed by medium-chain (C9-C12), saturated non-esterified fatty acids (NEFAs) on Aβ42 aggregation. NEFAs uniquely affected Aβ42 aggregation rates that depended on both the ratio of Aβ:NEFA as well the critical micelle concentration (CMC) of the NEFAs. More importantly, irrespective of the kind of NEFA used, we observed that two distinct oligomers, 12-18 mers and 4-5 mers were formed via different pathway of aggregation under specific experimental conditions: (i) 12-18 mers were generated near the CMC in which NEFAs augment the rate of Aβ42 aggregation towards fibril formation, and, (ii) 4-5 mers were formed above the CMC, where NEFAs inhibit fibril formation. The data indicated that both 12-18 mers and 4-5 mers are formed along an alternate pathway called 'off-pathway' that did not result in fibril formation and yet have subtle structural and morphological differences that distinguish their bulk molecular behavior. These observations, (i) reflect the possible mechanism of Aβ aggregation in physiological lipid-rich environments, and (ii) reiterate the fact that all oligomeric forms of Aβ need not be obligatory intermediates of the fibril formation pathway.
authors.affiliation: Department of Chemistry and Biochemistry, University of Southern Mississippi, Hattiesburg, Mississippi, United States of America.
authors.forename: Amit
authors.initials: A
authors.lastname: Kumar
authors.forename: Rebekah L
authors.initials: RL
authors.lastname: Bullard
authors.forename: Pritesh
authors.initials: P
authors.lastname: Patel
authors.forename: Lea C
authors.initials: LC
authors.lastname: Paslay
authors.forename: Dipti
authors.initials: D
authors.lastname: Singh
authors.forename: Ewa A
authors.initials: EA
authors.lastname: Bienkiewicz
authors.forename: Sarah E
authors.initials: SE
authors.lastname: Morgan
authors.forename: Vijayaraghavan
authors.initials: V
authors.lastname: Rangachari
mesh_terms: D016229:Amyloid beta-Peptides / Q000737:chemistry* / Q000302:isolation & purification; D052160:Benzothiazoles; D015153:Blotting, Western; D002942:Circular Dichroism; D005230:Fatty Acids, Nonesterified / Q000494:pharmacology*; D005453:Fluorescence; D019791:Guanidine / Q000494:pharmacology; D008823:Micelles; D008954:Models, Biological; D008970:Molecular Weight; D011489:Protein Denaturation / Q000187:drug effects; D020836:Protein Structure, Quaternary; D017433:Protein Structure, Secondary; D013816:Thermodynamics; D013844:Thiazoles / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D052160:Benzothiazoles; D005230:Fatty Acids, Nonesterified; D008823:Micelles; D013844:Thiazoles; C009462:thioflavin T; D019791:Guanidine